Anti-tumor effects of oxytetracycline, propafenone and dipyrone
An anti-tumor effect, propafenone technology, applied in the field of non-clinical anti-tumor drugs, can solve problems such as small toxic and side effects, achieve the effects of relieving the disease, large social and economic benefits, and inhibiting the progress of tumors
Inactive Publication Date: 2014-01-29
邵金辉
View PDF7 Cites 3 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
At present, there is almost no drug that can completely cure cancer patients such as lung cancer or cervical cancer. Therefore, it is very important to find an effective, specific, and less toxic and side effect new anti-tumor drug
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0019] Taking oxytetracycline, propafenone and metamizole while treating clinical lung cancer patients with conventional antineoplastic drugs can inhibit tumor progression to a certain extent and alleviate the patient's condition. Clinically, patients with cervical cancer who are treated with conventional antineoplastic drugs, taking the highest dose allowed by propafenone, can inhibit the progression of the tumor to a certain extent and alleviate the patient's condition.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more
Abstract
The invention relates to three non-clinical antitumor drugs which are found to have anti-tumor effects and mainly can inhibit the proliferation of lung cancer A549 cells or cervical cancer Hela cells. The technical problem to be solved is that some clinical drugs are screened by using the lung cancer A549 cells and the cervical cancer Hela cells, so as to obtain the non-clinical antitumor drugs with the antitumor effects. Key points of technical schemes for solving the problems are as follows: the lung cancer A549 cells and the cervical cancer Hela cells are processed for 48 hours by using drugs of saturated concentration, and the changes of the morphology and quantity of the cells are observed by a microscope; for drugs with inhibitory actions, survival rate and LDH (Lactate Dehydrogenase) activity detection is further carried out on the cells, and Hoechst33258 is applied to cell apoptosis detection. Main purposes: the non-clinical anticancer drugs for remarkably inhibiting the proliferation of the lung cancer A549 cells or cervical cancer Hela cells are found and are applied to the clinical treatment of patients with lung cancer or cervical cancer.
Description
technical field [0001] The present invention relates to the new functions of the anti-tumor effect of the three drugs. Specifically, the present invention relates to three non-clinical antitumor drugs, which are found to have antitumor effects, mainly to significantly inhibit the proliferation of lung cancer A549 cells or cervical cancer Hela cells. Background technique [0002] Clinical trials are the last step in the development of new drugs, and they cost huge sums of money. The new use of old drugs, especially the discovery of new uses of "old drugs" that have been used in long-term clinical practice, is of great significance, and its value is by no means lower than that of discovering a new drug. At present, there is almost no drug that can completely cure cancer patients such as lung cancer or cervical cancer. Therefore, it is very important to find an effective, specific, and less toxic and side effect new anti-tumor drug. [0003] Many new uses of old drugs are dis...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/65A61K31/4152A61K31/138A61P35/00
Inventor 邵金辉
Owner 邵金辉
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap